TY - JOUR T1 - Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations JO - Anales de Pediatría (English Edition) T2 - AU - Álvarez García,Francisco José AU - Cilleruelo Ortega,María José AU - Álvarez Aldeán,Javier AU - Garcés-Sánchez,María AU - García Sánchez,Nuria AU - Garrote Llanos,Elisa AU - Hernández Merino,Ángel AU - Iofrío de Arce,Antonio AU - Montesdeoca Melián,Abián AU - Navarro Gómez,María Luisa AU - Ruiz-Contreras,Jesús SN - 23412879 M3 - 10.1016/j.anpede.2020.10.004 DO - 10.1016/j.anpede.2020.10.004 UR - https://analesdepediatria.org/en-immunisation-schedule-pediatric-spanish-association-articulo-S2341287920302180 AB - The CAV-AEP annually publishes the immunisation schedule considered optimal for all children and adolescent resident in Spain, taking into account the available evidence.The 2+1 schedule is recommended (2, 4, and 11 months) with hexavalent vaccines (DTPa-VPI-Hib-HB) and with 13-valent pneumococcal conjugate. A 6-year booster is recommended, preferably with DTPa (if available), with a dose of polio for those who received 2+1 schemes, as well as vaccination with Tdpa in adolescents and in each pregnancy, preferably between 27 and 32 weeks.Rotavirus vaccine should be systematic for all infants.Meningococcal B vaccine, with a 2+1 schedule, should be included in routine calendar.In addition to the inclusion of the conjugated tetravalent meningococcal vaccine (MenACWY) at 12 years of age with catch up to 18 years, inclusive, the CAV recommends this vaccine to be also included at 12 months of age, replacing MenC. Likewise, it is recommended in those over 6 weeks of age with risk factors or who travel to countries with a high incidence of these serogroups.Two-dose schedules for triple viral (12 months and 3–4 years) and varicella (15 months and 3–4 years) will be used. The second dose could be applied as a tetraviral vaccine.Universal systematic vaccination against HPV is recommended, regardless of gender, preferably at 12 years, and greater effort should be made to improve coverage. The 9 genotype extends coverage for both genders. ER -